Microbix Biosystems Inc. (MBX : TSX)
Common Stock
$0.27
CAD
+0.01 (1.89%)
Last updated: 2026-06-05
MBX
Microbix Biosystems Inc.
WealthAwesomePerformance
1 Day
+1.89%
1 Week
+0.00%
1 Month
+10.20%
YTD
+12.50%
Key Statistics
Market Cap
$37.13M
52W High
$0.34
52W Low
$0.21
P/E Ratio
-
50 Day MA
$0.25
200 Day MA
$0.24
Beta
0.57
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 6/5/2026 | $0.27 | $0.27 | $0.27 | $0.27 | $0.27 | 1,100 |
| 6/4/2026 | $0.27 | $0.27 | $0.27 | $0.27 | $0.27 | 14,569 |
| 6/3/2026 | $0.26 | $0.27 | $0.26 | $0.27 | $0.27 | 6,042 |
| 6/2/2026 | $0.27 | $0.28 | $0.26 | $0.27 | $0.27 | 118,600 |
| 6/1/2026 | $0.28 | $0.28 | $0.27 | $0.27 | $0.27 | 24,097 |
| 5/29/2026 | $0.28 | $0.28 | $0.27 | $0.27 | $0.27 | 33,258 |
| 5/28/2026 | $0.28 | $0.28 | $0.26 | $0.28 | $0.28 | 190,765 |
| 5/27/2026 | $0.27 | $0.28 | $0.26 | $0.28 | $0.28 | 82,772 |
| 5/26/2026 | $0.26 | $0.27 | $0.26 | $0.27 | $0.27 | 91,850 |
| 5/25/2026 | $0.24 | $0.26 | $0.24 | $0.26 | $0.26 | 94,011 |
Analyst Price Targets
Based on analyst covering MBX
Wall Street analysts forecast MBX stock price to rise 48.1% over the next 12 months.
Consensus
No RatingAvg. Target
C$0.40
+48.1% Upside
Current Price
C$0.27
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MBX's historical volatility
30-Day Vol
58.0%
Annualized
90-Day Vol
56.9%
Annualized
Trend (90d)
+15.9%
Annualized drift
90d Mean
C$0.29
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$0.28 | C$0.23 โ C$0.34 |
| 60 trading days | C$0.28 | C$0.21 โ C$0.37 |
| 90 trading days | C$0.29 | C$0.20 โ C$0.40 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Microbix Biosystems Inc.
Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures a wide range of critical biological materials and medical devices for the global diagnostics industry, notably test ingredients (Antigen business) used in immunoassays, quality assessment, and diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for enabling the collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. It also provides customer vial filling services. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.
Financials
- Revenue (TTM)
- $14.81M
- EBITDA
- $-3.87M
- Profit Margin
- -38.62%
- ROE (TTM)
- -20.36%
- EPS (Diluted)
- -0.04
- Book Value
- 0.18
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
Advertisement
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Common Questions About MBX
Articles Featuring MBX.TO
Latest articles and analysis covering MBX.TO
